AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

PFIZER'S INHALED INSULIN PERMITTED FOR TRIALS IN INDIA (trials will be conducted by Quintiles in India).

India Business Insight

| December 31, 2006 | COPYRIGHT 2001 Silverline Information Systems Pvt. Ltd. (Hide copyright information)Copyright

(From India Business Insight)

Pfizer has obtained permission to conduct clinical trials in India for Exubera, inhaled insulin drug candidate, which is used for the treatment of Type 1 …

Related articles from newspapers, magazines, journals, and more
ELI LILLY SET TO CONDUCT TRIALS ON INHALED INSULIN (volume of research in...
News wire article from: Asia Africa Intelligence Wire August 10, 2005 700+ words
PFIZER'S INHALED INSULIN PERMITTED FOR TRIALS IN INDIA (Quintiles will...
Magazine article from: India Business Insight December 31, 2005 700+ words
Lilly and Alkermes complete patient enrollment for Phase III safety study for...
News wire article from: Chemical Business Newsbase June 5, 2006 700+ words
Generex Biotechnology Corp (GNBT) provides update on Generex Oral-lyn in India.
News wire article from: Chemical Business Newsbase March 11, 2009 700+ words
Nektar India launches R&D centre to boost drug discovery.
News wire article from: Chemical Business Newsbase December 5, 2005 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily